X

Health Care

Abbvie’s oncology push makes it an attractive stock

Abbvie (NYSE: ABBV) is one of the worse performing pharma stocks in the trailing 12-month period. The stock has declined…

HEXO Corp (HEXO) disappoints in Q3

Late on Wednesday, HEXO Corp (TSX: HEXO; NYSE-A: HEXO) reported a basic net loss per share that widened to CAD…

Neptune Wellness posts wider losses in Q4, shares fall

Canadian producer of wellness products, Neptune Wellness Solutions (NASDAQ: NEPT), said its revenues fell 16% in the first quarter to…

Catalent stock soars to record high

Catalent Inc. (CTLT) stock soared to a record high of $50.62 on Wednesday as investors were satisfied with the company's…

Summit Therapeutics reports loss of $0.04 per share for Q1

Summit Therapeutics (NASDAQ: SMMT) reported a narrower-than-expected loss for the first quarter of 2019 while revenues missed estimates. The stock…

CymaBay Therapeutics stock drops to 2-year low after bitter NASH study data

CymaBay Therapeutics (NASDAQ: CBAY) stock fell to a two-year low of $4.82 on Tuesday after disappointing nonalcoholic steatohepatitis (NASH) trial…

Advaxis’ revenue declines in Q2 as Amgen terminaties collaboration agreement

Advaxis (NASDAQ: ADXS) reported that Q2 revenue decreased to $1.2 million from $1.7 million in the prior year quarter. The…

Earnings preview: Advaxis stock treading near an all-time low ahead of Q2 results

Late-stage biotech firm Advaxis, Inc. (NASDAQ: ADXS) is scheduled to report second-quarter financial results on June 10, Monday, after the…

Tilray stock heads downward on doubts of cannabis risks

Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward…

What’s in store for top pharma stocks this year

The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note,…

CVS’ stock gains as company lays out growth strategy

CVS Health’s (NYSE: CVS) shares were up 3.2% in afternoon hours as the company outlined its growth strategy and reaffirmed…

WeedMD posts wider loss in Q1 but revenue soars 192%

Medical-grade cannabis producer WeedMD Inc. reported a wider loss in the first quarter of 2019 due to higher costs and…

Veeva Systems reports stellar Q1 earnings, outlook beat estimates

Veeva Systems (NYSE: VEEV) reported yet another solid earnings beating analyst estimates. The company also raised its full-year outlook and…

Looming opioid epidemic calls for stricter drug regulation

Though the healthcare industry is slowly waking up to the hazards of opioid-based prescription drugs, their sale continues unabated across…

Soliton spikes over 50% on its decision to proceed with cellulite trials

Shares of Soliton Inc. (NASDAQ: SOLY) jumped over 50% during the morning trade on Wednesday after the medical device company…

Charlotte’s Web Holdings retains full-year outlook; to delist from CSE

Charlotte’s Web Holdings (CSE: CWEB; OTCQX: CWBHF) first-quarter results came in line with the preliminary guidance provided earlier this month.…

Earnings Preview: Charlotte’s Web to report solid Q1 results aided by multiple tailwinds

Charlotte's Web Holdings (CSE: CWEB; OTCQX: CWBHF) is planning to report its first-quarter results tomorrow after the bell. The company…

Novartis’ one-time gene therapy for spinal muscular atrophy gets FDA nod

Picture Courtesy: Novartis Zolgensma, a gene-based treatment from Novartis (NYSE: NVS) for the treatment of spinal muscular atrophy that affects…

Centene stock spikes as activist investor Third Point pushes for its sale

Shares of Centene Corp (NYSE: CNC) shot up over 3% on average volume on Friday, after it was revealed that…

Medtronic tops expectations on Q4 results

Medtronic plc (NYSE: MDT) reported revenue and earnings for the fourth quarter of 2019 that topped market expectations. Shares rose…

Affimed’s stock tanks as company announces termination of cancer program

Affimed NV (NASDAQ: AFMD) reported first-quarter 2019 earnings results and announced its plans to terminate its cancer program while focusing…